Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Introducing Rapid Diagnostic Tests Into the Private Health Sector

This study has been completed.
Sponsor:
Collaborators:
Ministry of Health, Uganda
London School of Hygiene and Tropical Medicine
Artemisinin-based Combination Therapy
Information provided by (Responsible Party):
Pascal Magnussen, DBL -Institute for Health Research and Development
ClinicalTrials.gov Identifier:
NCT01194557
First received: September 2, 2010
Last updated: October 11, 2012
Last verified: October 2012